A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
- Status
- TERMINATED
- Phase
- PHASE3
Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants
- Status
- COMPLETED
- Phase
- PHASE4
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
- Status
- RECRUITING
- Phase
- PHASE2
Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- Status
- SUSPENDED
- Phase
- PHASE1
Autologous Transplant Targeted Against Crohn's
- Status
- WITHDRAWN
- Phase
- PHASE2
Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
- Status
- TERMINATED
- Phase
- PHASE3
Everolimus Monotherapy as Immunosuppression After Liver Transplant
- Status
- TERMINATED
- Phase
- PHASE3
Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
- Status
- COMPLETED
- Phase
- PHASE4
Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome
- Status
- UNKNOWN
- Phase
- N/A
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE4
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
- Status
- COMPLETED
- Phase
- PHASE4
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
- Status
- TERMINATED
- Phase
- PHASE2
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
- Status
- COMPLETED
- Phase
- PHASE3